Unternehmensaktivitäten und -maßnahmen

Bayer

Mitglied des UN Global Compact

Hauptsitz in Deutschland

Bayer website

🔎 Run a search for “Bayer”

Get RSS feed of these results

Alle Stories

Artikel
23 October 2001
+ English - Verbergen

Autor/in: Oxfam America

Oxfam America is calling on the US to follow the lead of the Canadian government and issue a compulsory license to enable a local US manufacturer to supply Cipro. "The US insistence on protecting Bayer's patents should not be at the expense of people's...

Mehr

  • Betreffende Unternehmen: Bayer
Artikel
23 October 2001
+ English - Verbergen

Autor/in: Robert Fife, National Post [Canada]

...a more senior official said Mr. Rock had little choice but to come to terms with Bayer because his department had breached the drug giant's legal patent, potentially threatening the $1-billion a year the pharmaceutical industry invests in Canada....

Mehr

Artikel
22 October 2001
+ English - Verbergen

Autor/in: editorial, San Francisco Chronicle

...The Bush administration says it has pushed Bayer for extra Cipro supplies, but has refused to override patent laws, which it could arguably do...Washington's hesitancy has other sources. If drug licensing laws are suspended for Cipro, what about big...

Mehr

  • Betreffende Unternehmen: Bayer
Artikel
22 October 2001
+ English - Verbergen

Autor/in: Vanessa Fuhrmans and Ron Winslow, Wall Street Journal

...New York Sen. Charles Schumer questioned whether Bayer could meet soaring demand for the potent anthrax antibiotic and called for government action to allow generic production. Sunday, Senate minority leader Trent Lott predicted the Senate would...

Mehr

  • Betreffende Unternehmen: Bayer
Artikel
20 October 2001
+ English - Verbergen

Autor/in: editorial, The Ottawa Citizen

...Worried about bioterrorism, Health Canada has ordered 900,000 generic copies of an anti-anthrax pill from a firm that doesn't hold the patent. The government has bypassed the true patent-holder, on the reasonable-sounding grounds that anthrax is a...

Mehr

  • Betreffende Unternehmen: Bayer
Artikel
19 October 2001
+ English - Verbergen

Autor/in: Guardian [UK]

Canada's decision to override a patent on the anti-anthrax drug Cipro angered officials with German drugmaker Bayer AG, who said Friday they were seeking talks with the country's ministry of health. Canadian health officials said Thursday they would...

Mehr

  • Betreffende Unternehmen: Bayer
Artikel
19 October 2001
+ English - Verbergen

Autor/in: Dennis Bueckert, Canadian Press

Health Minister Allan Rock is refusing to say whether his department violated patent law in ordering a large amount of anti-anthrax medication from a generic drug company. Nor would Rock say whether he will stick with generic drug manufacturer Apotex...

Mehr

Artikel
19 October 2001
+ English - Verbergen

Autor/in: Domenic Fazioli, Global Television Montreal

...The federal government can override a patent in emergency situations. But, an official emergency has not been declared. And, now Bayer is upset it was never even consulted. The German-based pharmaceutical company is even thinking about suing....

Mehr

  • Betreffende Unternehmen: Bayer
Story
17 October 2001
+ English - Verbergen
Artikel
1 January 2001
+ English - Verbergen

Autor/in: Bayer

Mehr

  • Betreffende Unternehmen: Bayer